MRNS – Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc.MRNS
$0.5399Name : Marinus Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $29,812,468.00
EPSttm : -2.47
Marinus Pharmaceuticals, Inc.
$0.5399
0.22%$0.0012Float Short %
8.65
Margin Of Safety %
Put/Call OI Ratio
0.02
EPS Next Q Diff
0.24
EPS Last/This Y
0.63
EPS This/Next Y
1.28
Price
0.54
Target Price
1.07
Analyst Recom
2.71
Performance Q
-70.01
Relative Volume
0.39
Beta
1.03
Ticker: MRNS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | MRNS | 0.24 | 0.03 | 1.00 | 8031 |
| 2024-12-20 | MRNS | 0.2387 | 0.03 | 0.18 | 8033 |
| 2024-12-23 | MRNS | 0.2318 | 0.03 | 0.00 | 7301 |
| 2024-12-24 | MRNS | 0.2572 | 0.03 | 0.00 | 7311 |
| 2024-12-26 | MRNS | 0.3279 | 0.03 | 0.08 | 7315 |
| 2024-12-27 | MRNS | 0.379 | 0.03 | 0.00 | 7339 |
| 2024-12-30 | MRNS | 0.53 | 0.03 | 0.01 | 8521 |
| 2024-12-31 | MRNS | 0.5329 | 0.03 | 0.01 | 14341 |
| 2025-01-02 | MRNS | 0.5287 | 0.02 | 0.04 | 14692 |
| 2025-01-03 | MRNS | 0.536 | 0.02 | 0.01 | 14840 |
| 2025-01-06 | MRNS | 0.5365 | 0.02 | 0.00 | 14797 |
| 2025-01-07 | MRNS | 0.5321 | 0.02 | 0.00 | 15129 |
| 2025-01-08 | MRNS | 0.532 | 0.02 | 0.00 | 15264 |
| 2025-01-09 | MRNS | 0.532 | 0.02 | 0.00 | 15264 |
| 2025-01-10 | MRNS | 0.537 | 0.02 | 0.00 | 15234 |
| 2025-01-13 | MRNS | 0.5422 | 0.02 | 0.02 | 15280 |
| 2025-01-14 | MRNS | 0.5394 | 0.02 | 0.00 | 15291 |
| 2025-01-15 | MRNS | 0.542 | 0.02 | 0.00 | 15291 |
| 2025-01-16 | MRNS | 0.543 | 0.02 | 0.00 | 15282 |
| 2025-01-17 | MRNS | 0.541 | 0.02 | 0.01 | 15281 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | MRNS | 0.24 | 64.7 | - | -2.00 |
| 2024-12-20 | MRNS | 0.24 | 64.7 | - | -2.00 |
| 2024-12-23 | MRNS | 0.24 | 64.7 | - | -2.00 |
| 2024-12-24 | MRNS | 0.26 | 64.7 | - | -2.00 |
| 2024-12-26 | MRNS | 0.32 | 64.7 | - | -2.00 |
| 2024-12-27 | MRNS | 0.38 | 64.7 | - | -2.00 |
| 2024-12-30 | MRNS | 0.53 | 64.7 | - | -2.00 |
| 2024-12-31 | MRNS | 0.54 | 64.7 | - | -2.00 |
| 2025-01-02 | MRNS | 0.53 | 64.7 | - | -2.00 |
| 2025-01-03 | MRNS | 0.54 | 64.7 | - | -2.00 |
| 2025-01-06 | MRNS | 0.53 | 64.7 | - | -2.00 |
| 2025-01-07 | MRNS | 0.53 | 64.7 | - | -2.00 |
| 2025-01-08 | MRNS | 0.53 | 64.7 | - | -2.00 |
| 2025-01-09 | MRNS | 0.53 | 64.7 | - | -2.00 |
| 2025-01-10 | MRNS | 0.54 | 64.7 | - | -2.00 |
| 2025-01-13 | MRNS | 0.54 | 64.7 | - | -2.00 |
| 2025-01-14 | MRNS | 0.54 | 64.7 | - | -2.00 |
| 2025-01-15 | MRNS | 0.54 | 64.7 | - | -2.00 |
| 2025-01-16 | MRNS | 0.54 | 64.7 | - | -2.00 |
| 2025-01-17 | MRNS | 0.54 | 64.7 | - | -2.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | MRNS | -0.22 | -16.13 | 10.46 |
| 2024-12-20 | MRNS | -0.22 | -16.13 | 10.46 |
| 2024-12-23 | MRNS | -0.23 | -16.13 | 10.46 |
| 2024-12-24 | MRNS | -0.23 | -16.13 | 10.46 |
| 2024-12-26 | MRNS | -0.20 | -16.13 | 10.30 |
| 2024-12-27 | MRNS | -0.22 | -16.13 | 10.30 |
| 2024-12-30 | MRNS | -0.19 | -16.17 | 10.30 |
| 2024-12-31 | MRNS | -0.19 | -16.17 | 10.30 |
| 2025-01-02 | MRNS | -0.21 | -16.17 | 10.30 |
| 2025-01-03 | MRNS | -0.22 | -16.17 | 10.30 |
| 2025-01-06 | MRNS | -0.22 | -16.31 | 10.30 |
| 2025-01-07 | MRNS | -0.22 | -16.31 | 10.30 |
| 2025-01-08 | MRNS | -0.22 | -16.31 | 10.30 |
| 2025-01-09 | MRNS | -0.22 | -16.31 | 10.30 |
| 2025-01-10 | MRNS | -0.22 | -16.31 | 10.30 |
| 2025-01-13 | MRNS | -0.22 | -16.31 | 8.65 |
| 2025-01-14 | MRNS | -0.22 | -16.31 | 8.65 |
| 2025-01-15 | MRNS | -0.22 | -16.31 | 8.65 |
| 2025-01-16 | MRNS | -0.22 | -16.31 | 8.65 |
| 2025-01-17 | MRNS | -0.22 | -16.31 | 8.65 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.42
Avg. EPS Est. Current Quarter
-0.28
Avg. EPS Est. Next Quarter
-0.18
Insider Transactions
-0.22
Institutional Transactions
-16.31
Beta
1.03
Average Sales Estimate Current Quarter
10
Average Sales Estimate Next Quarter
10
Fair Value
Quality Score
21
Growth Score
38
Sentiment Score
42
Actual DrawDown %
97.3
Max Drawdown 5-Year %
-98.8
Target Price
1.07
P/E
Forward P/E
PEG
P/S
0.95
P/B
P/Free Cash Flow
EPS
-2.47
Average EPS Est. Cur. Y
-2
EPS Next Y. (Est.)
-0.72
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-446.49
Relative Volume
0.39
Return on Equity vs Sector %
191.4
Return on Equity vs Industry %
204
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.14
EBIT Estimation
Marinus Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 165
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY (ganaxolone), an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, and tuberous sclerosis complex. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation and Tenacia Biotechnology (Shanghai) Co., Ltd. Marinus Pharmaceuticals, Inc. was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.
stock quote shares MRNS – Marinus Pharmaceuticals, Inc. Stock Price stock today
news today MRNS – Marinus Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRNS – Marinus Pharmaceuticals, Inc. yahoo finance google finance
stock history MRNS – Marinus Pharmaceuticals, Inc. invest stock market
stock prices MRNS premarket after hours
ticker MRNS fair value insiders trading